相关实验视频

Updated: Sep 17, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

患有多发性骨髓瘤和处方尿酸降低疗法的患者的结果:一项倾向匹配的研究

Sarah Eidbo¹, Maxim Barnett¹, Diego Lema Rodriguez¹

¹Internal Medicine, Jefferson Einstein Philadelphia Hospital, Philadelphia, USA.

|July 4, 2025

概括

尿酸降低疗法 (ULT) 可能增加透析,心律失常和多发性骨髓瘤 (MM) 患者的死亡风险. 需要进一步的研究,以了解这些ULT特异性关系和潜在的复合效应与痛风.

科学领域:

在瘤学瘤学.
腎臟病學 (nephrology) 是一種醫學專業.
心脏病学心脏病学
类风湿病学类风湿病学

背景情况:

多发性骨髓瘤 (MM) 是一种血细胞疾病,导致器官功能障碍.
痛风与由于电解质失衡导致的末端器官功能障碍有相似之处.
有限的数据存在于MM和痛风患者的结局.

研究的目的:

研究尿酸降低疗法 (ULT) 对多发性骨髓瘤 (MM) 患者结局的影响.
为了比较MM患者和没有ULT患者之间的结果,包括特殊药物,如allopurinol,febuxostat和rasburicase.
评估ULT与急性损伤 (AKI),透析启动 (HD),发作,心律失常和死亡率的关联.

主要方法:

成年MM患者通过TriNetX通过ICD-10代码进行鉴定.
患者的倾向性得分与人口统计学和并发症相匹配.
队列根据ULT使用 (阿洛普林醇,费布克斯托特,拉斯布里卡斯,任何ULT或没有ULT) 进行了分层分类,并在5年内进行了跟踪.

主要成果:

与任何ULT患者相比,没有ULT的MM患者的HD,心房动/动 (AF/AFL),心室动/心跳动 (VF/VT) 和死亡率明显较低.
与其使用相比,阿洛普林醇的缺失与AKI,HD,发作,AF/AFL,VF/VT和死亡率显著降低有关.
与它们的使用相比,缺乏febuxostat和rasburicase也显示了AF/AFL的降低率,这表明潜在的ULT特异性影响.

结论:

ULT可能会增加需要透析的风险,发展心律失常,并可能增加MM患者的死亡率.
特定的ULT可能与不良结果有明显的关联,需要进一步调查.
毫米和痛风对电解质干扰和末端器官功能障碍的综合影响可能会影响这些结果.

关键词:

我们的数据库数据库数据库数据库.痛风是一种痛风.多发性骨髓瘤是多发性骨髓瘤的一种.在Trinetx中使用.尿酸降血疗法可以降低尿酸.

更多相关视频

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Urinary Tract Calculi III: Medical Management

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...